Geneos Wealth Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Geneos Wealth Management's OGN Position: Q2 2026 in Review
Geneos Wealth Management reduced its Organon & Co (OGN) stake by 3.6% in Q2 2026, selling an estimated $239 and leaving 537 shares worth $7.27K. The position accounts for ﹤0.01% of the portfolio, ranked #2091.
Geneos Wealth Management first reported a position in OGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $131K in Q1 2022. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Geneos Wealth Management held 537 shares of Organon & Co worth $7.27K as of Q2 2026.
- Geneos Wealth Management sold 20 Organon & Co shares in Q2 2026, an estimated $239.
- Organon & Co made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2091 holding.
- Geneos Wealth Management first reported a position in Organon & Co in Q1 2022 and has held it in 18 quarters since.
- Geneos Wealth Management's Organon & Co position peaked at $131K in Q1 2022.
- 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.